Filtered By:
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 2010 results found since Jan 2013.
Exam 3: Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases
Source: Clinical Gastroenterology and Hepatology - April 4, 2019 Category: Gastroenterology Tags: Continuing Medical Education (CME) Activity Source Type: research
Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease
CONCLUSIONS: There is room for improvement of vaccination recommendations by PCPs. Promoting continuing education and use of clinical tools may help support PCP immunization practices for patients with IBD.PMID:35779060 | DOI:10.1093/ibd/izac129
Source: Herpes - July 2, 2022 Category: Infectious Diseases Authors: Fang Xu Neal deJong Michael D Kappelman Kurt J Greenlund Susan A Carlson Source Type: research
Evaluating public interest in herpes zoster in Germany by leveraging the internet: a retrospective search data analysis
CONCLUSIONS: The study demonstrated that evaluating internet search data is a viable method for assessing public interest in HZ, thereby identifying areas of unmet need to support targeted public health campaigns.PMID:37580664 | DOI:10.1186/s12889-023-16463-4
Source: Herpes - August 14, 2023 Category: Infectious Diseases Authors: Alphina Kain Linda Tizek Hannah Wecker Fabian Walln öfer Tilo Biedermann Alexander Zink Source Type: research
Herpes zoster vaccination efficacy in the long-term care facility population: a qualitative systematic review.
CONCLUSIONS: The studies reviewed showed efficacy of the HZ vaccine in relevant elderly populations residing either in LTCF or in the community including those of advanced age with multiple comorbidities. Consideration can be given to the use of HZ vaccine for individuals over 60 in LTCF, as well as in the community.
PMID: 30913912 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - March 29, 2019 Category: Research Tags: Curr Med Res Opin Source Type: research
Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer
As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects.
On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week.
Related: Emergency Considerations in COVID-19 Vaccine Administration
In the U.S., vaccine recipients are supposed ...
Source: JEMS: Journal of Emergency Medical Services News - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news
Vaccines for preventing herpes zoster in older adults.
CONCLUSIONS: Herpes zoster vaccine is effective in preventing herpes zoster disease. Although vaccine benefits are larger in the younger age group (60 to 69 years), this is also the age group with more adverse events. In general, zoster vaccine is well tolerated; it produces few systemic adverse events and injection site adverse effects of mild to moderate intensity.
PMID: 25055074 [PubMed - as supplied by publisher]
Source: Sao Paulo Medical Journal - July 24, 2014 Category: Journals (General) Authors: Gagliardi AM, Silva BN, Torloni MR, Soares BG Tags: Sao Paulo Med J Source Type: research
Hopkins Nursing—Dean on Education and Moving Forward
body,#bodyTable,#bodyCell{
height:100% !important;
margin:0;
padding:0;
width:100% !important;
}
table{
border-collapse:collapse;
}
img,a img{
border:0;
outline:none;
text-decoration:none;
}
h1,h2,h3,h4,h5,h6{
margin:0;
padding:0;
}
p{
margin:1em 0;
padding:0;
}
a{
word-wrap:break-word;
}
.mcnPreviewText{
display:none !important;
}
.ReadMsgBody{
width:100%;
}
.ExternalClass{
width:100%;
}
.ExternalClass,.ExternalClass p,.ExternalClass span,.ExternalClass font,.ExternalClass td,.ExternalClass div{
line-height:100%;
}
table,td{...
Source: Johns Hopkins University and Health Systems Archive - March 28, 2018 Category: Nursing Source Type: news
Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence
CONCLUSIONS: RZV may be cost-effective for vaccination in ages of 60-79 years for both SP and TPP perspectives, while ZVL might be cost-effective in some age groups, but results are not robust.PMID:34791974 | DOI:10.1080/13696998.2021.2008195
Source: Journal of Medical Economics - November 18, 2021 Category: Health Management Authors: Sariya Udayachalerm Maranda G Renouard Thunyarat Anothaisintawee Ammarin Thakkinstian Sajesh K Veettil Nathorn Chaiyakunapruk Source Type: research
Examples of Outcome Reporting Bias in Vaccine Studies: Illustrating How Perpetuating Medical Consensus Can Impede Progress in Public Health
CONCLUSIONS: Conflicts of interest (e.g., financial) that abound between health regulatory agencies and the pharmaceutical industry impact what is ultimately reckoned as medical consensus. Outcome reporting bias that is inherent to all researchers to some degree, obscures medical and scientific truth. Advancement of public health requires that researchers have integrity and an openness and willingness to collaborate to resolve contradictory findings. In fact, it is usually through meticulous, rigorous, scientific investigation of contradictory findings that medical science has advanced and contributed to improvements in pu...
Source: Herpes - October 28, 2022 Category: Infectious Diseases Authors: Gary S Goldman Source Type: research
Herpes zoster and the search for an effective vaccine.
This article reviews VZV pathogenesis, host responses and current vaccines available to prevent herpes zoster. This article is protected by copyright. All rights reserved.
PMID: 27164323 [PubMed - as supplied by publisher]
Source: Clinical and Developmental Immunology - May 9, 2016 Category: Allergy & Immunology Authors: Arnold N, Messaoudi I Tags: Clin Exp Immunol Source Type: research
